Infectious Disease Research

The Wake Forest School of Medicine Section on Infectious Diseases integrates clinical excellence, epidemiology, and data‑driven modeling to address emerging and endemic infectious threats.

Advancing Infectious Disease Research, Surveillance, and Public Health Response

The Wake Forest University School of Medicine Section on Infectious Diseases integrates clinical excellence, epidemiology, and data‑driven modeling to address emerging and endemic infectious threats.

Picture of the Wake Forest University School of Medicine Section on Infectious Diseases.

Wake Forest University School of Medicine Section on Infectious Diseases is home to not only excellence in clinical care but also research and education. Our infectious diseases specialists are recognized locally, nationally and internationally for their expertise in treating all types of infectious diseases. We are home to professional researchers, clinical trialists, and support staff engaged in everything from basic and translational research to infectious disease epidemiology and public health.

Read more about our latest news and insights!

Respiratory Virus Surveillance

Check out our current work on respiratory virus surveillance. This includes COVID-19, influenza, RSV, and other respiratory viruses. As part of a Duke Endowment grant, we are working to improve respiratory virus surveillance in North Carolina and communicating the results directly to the public and our public health partners.

Recent publications

Train with us

The Wake Forest University School of Medicine Infectious Disease offers a variety of training opportunities for undergraduates, medical students, residents, fellows, and pharmacy residents. Learn more about our training opportunities.

Support our work

Every gift contributes to our mission of building a better future for all. To learn more about how you can support the Section on Infectious Diseases, please contact the Office of Philanthropy at philanthropy@wakehealth.edu or give online below.

Give Now Online

Please put “Section on Infectious Diseases” in the comments field when you give online.

Upcoming events

Elisabeth Marnik, Ph.D.
M. Elle Saine, MD, PhD, MA
Feb 13, 2026 @ 12:00 PM · ID Conference Room (In person only)

Navigating the noise: how to combat misinformation

Elisabeth Marnik, Ph.D. (Speaker) – Executive Director, The Evidence Collective

Dr. Elisabeth Adkins Marnik is a scientist, educator, and nationally recognized science communicator dedicated to making science accessible, engaging, and relevant to all audiences. As the Executive Director of The Evidence Collective, she leads national efforts to translate evidence into accessible, responsible public communication and to support independent voices working at the intersection of science, health, and policy. Her work focuses on building trust, countering false information, and ensuring communities have access to science they can use in their daily lives. As Chief Scientific Officer for Those Nerdy Girls, she helps shape evidence-based communication for world-wide readers, emphasizing empathy, clarity, and trust-building in the face of false information. Through Science Whiz Liz, she creates accessible content that makes science feel human and empowering. Liz’s work has been featured on Science Friday, HuffPost, and other media outlets, and she was named to Mainebiz’s 2025 “40 Under 40” list for her leadership and public impact.

M. Elle Saine, MD, PhD, MA (Moderator) – Postdoctoral Fellow, Infectious Diseases, Perelman School of Medicine, University of Pennsylvania

M. Elle Saine, MD, PhD, MA is an infectious diseases physician-scientist at the Hospital of the University of Pennsylvania whose research examines how stigma shapes health care access, policy, and equity. Her work focuses on the intersection of infectious disease epidemics—including HIV and viral hepatitis—and the opioid crisis, using innovative mixed methods approaches to identify and reduce structural barriers to care. She is a member of the SHEA Public Policy and Government Affairs Committee and the Vice-Chair of the Community Health and Prevention Impact Area at Doctors for America.

Past events

Dr Rana Hajjeh
Jan 30, 2026 @ 12:00 PM · GI Conference Room

Infectious diseases and Public Health- A global perspective with focus on the Middle East

Dr Rana Hajjeh – Former Director of Programme Management World Health Organization (WHO)

Dr Hajjeh is a senior public health leader with 30 years experience in global health, infectious diseases epidemiology, health policy and diplomacy, and health management, especially in the Eastern Mediterranean Region.

Dr David Brett-Major
Oct 02, 2025 @ 11:00 AM · ID Conference Room

Building Infectious Disease Surveillance Platforms

Dr David Brett-Major – Professor of Infectious Diseases and Epidemiology, University of Nebraska Medical Center

David Brett-Major, MD, MPH, is a professor in the Department of Epidemiology of the UNMC College of Public Health and has extensive experience in biosecurity and surveillance.

Dr Dan Bausch
Apr 27, 2025 @ 10:30 AM · Sticht Center - Hubbard Learning Center

The evolution of clinical care for the viral hemorrhagic fevers over the years

Dr Dan Bausch – Professor, London School of Hygiene and Tropical Medicine & National University Singapore

Dr Bausch specializes in the research and control of emerging tropical viruses, with over 20 years’ experience in sub-Saharan Africa, Latin America, and Asia combating viruses such as Ebola, Lassa, hantavirus, and SARS coronavirus. He places a strong emphasis on capacity building in all his projects and has a keen interest in the role of the scientist in promoting health and human rights.

Dr Rodolphe Barrangou
Sep 19, 2024 @ 12:00 PM · Comprehensive Cancer Center (10th Floor Boardroom)

The CRISPR toolbox and its applications in medicine: infectious disease, microbiome and therapeutic applications.

Dr Rodolphe Barrangou – Todd R. Klaenhammer Distinguished Professor, North Carolina State University

Dr. Barrangou established the functional role of CRISPR-Cas as adaptive immune systems in bacteria. He has focused on establishing the molecular basis for their mechanism of action, as well as developing and applying CRISPR-based technologies for genotyping, building immunity and genome editing

Dr Christina Coyle
Jun 06, 2024 @ 03:00 PM · Commons

Update on the management of neurocysticerosis

Dr Christina Coyle – Professor of Medicine and Pathology, Albert Einstein College of Medicine

Dr. Coyle runs an active clinic at Jacobi Medical Center where she trains fellows, medical students and residents. She co-directs the American Society of Tropical Medicine Annual Intensive Update Course. She is recognized by her colleagues as an expert in this field and lectures widely nationally and internationally. In 2007, she became a site director for GeoSentinel, a worldwide communication and data collection network for the surveillance of travel-related morbidity. She has a deep expertise in medical parasitology.

Dr Tom Chiller
Jan 19, 2023 @ 08:00 AM · Commons

Fungus Among US: Emerging Fungal Resistance, Candida Auris And Beyond

Dr Tom Chiller – Chief, Mycotic Diseases Branch; Associate Director for Global Health, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, USA

At the CDC, Tom Chiller provides leadership for fungal disease activities, which include detection, prevention and response activities, policy and advocacy, both nationally and internationally. He also serves as the associate director for global programs in the Division of Foodborne, Waterborne, and Environmental Diseases. He remains actively involved in antimicrobial resistance, healthcare associated infections, molecular epidemiology and laboratory activities for fungal diseases.